ALB and pancreatic neoplasm: The Food and Drug Administration (FDA) has approved albumin-bound paclitaxel (nab-PTX) NPs as a primary treatment for advanced pancreatic cancer, and nab-PTX NPs show high treatment efficacy [4,5].